Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study.
Emamzadehfard S, Kamaloo A, Paydary K, Ahmadipour A, Zeinoddini A, Ghaleiha A, Mohammadinejad P, Zeinoddini A, Akhondzadeh S. Emamzadehfard S, et al. Among authors: mohammadinejad p. Psychiatry Clin Neurosci. 2016 Aug;70(8):332-41. doi: 10.1111/pcn.12394. Epub 2016 May 26. Psychiatry Clin Neurosci. 2016. PMID: 27106362 Free article. Clinical Trial.
Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
Ghaleiha A, Alikhani R, Kazemi MR, Mohammadi MR, Mohammadinejad P, Zeinoddini A, Hamedi M, Shahriari M, Keshavarzi Z, Akhondzadeh S. Ghaleiha A, et al. Among authors: mohammadinejad p. J Child Adolesc Psychopharmacol. 2016 Nov;26(9):784-791. doi: 10.1089/cap.2015.0175. Epub 2016 Apr 29. J Child Adolesc Psychopharmacol. 2016. PMID: 27128958 Clinical Trial.
A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania.
Mousavi SY, Khezri R, Karkhaneh-Yousefi MA, Mohammadinejad P, Gholamian F, Mohammadi MR, Zeinoddini A, Akhondzadeh S. Mousavi SY, et al. Among authors: mohammadinejad p. J Child Adolesc Psychopharmacol. 2017 Aug;27(6):494-500. doi: 10.1089/cap.2016.0207. Epub 2017 Apr 14. J Child Adolesc Psychopharmacol. 2017. PMID: 28409660 Clinical Trial.
Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients with Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study.
Nikbakhat MR, Arabzadeh S, Zeinoddini A, Khalili Z, Rezaei F, Mohammadinejad P, Ghaleiha A, Akhondzadeh S. Nikbakhat MR, et al. Among authors: mohammadinejad p. Pharmacopsychiatry. 2016 Jul;49(4):162-9. doi: 10.1055/s-0042-101557. Epub 2016 Feb 22. Pharmacopsychiatry. 2016. PMID: 26902281 Clinical Trial.
Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study.
Amidfar M, Khiabany M, Kohi A, Salardini E, Arbabi M, Roohi Azizi M, Zarrindast MR, Mohammadinejad P, Zeinoddini A, Akhondzadeh S. Amidfar M, et al. Among authors: mohammadinejad p. J Clin Pharm Ther. 2017 Feb;42(1):44-50. doi: 10.1111/jcpt.12469. Epub 2016 Nov 3. J Clin Pharm Ther. 2017. PMID: 27809351 Clinical Trial.
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial.
Iranpour N, Zandifar A, Farokhnia M, Goguol A, Yekehtaz H, Khodaie-Ardakani MR, Salehi B, Esalatmanesh S, Zeionoddini A, Mohammadinejad P, Zeinoddini A, Akhondzadeh S. Iranpour N, et al. Among authors: mohammadinejad p. Hum Psychopharmacol. 2016 Mar;31(2):103-12. doi: 10.1002/hup.2517. Epub 2016 Feb 8. Hum Psychopharmacol. 2016. PMID: 26856695 Clinical Trial.
68 results